Available in India since 2008, Cervarix is prescribed for females from 10 to 45 years of age and its two doses are indicated ...

The next HPV vaccine approved in the United States, called Cervarix, is a bivalent vaccine that protects against HPV types 16 and 18 and was approved for use in females ages 9 to 26. Gardasil 9 ...

14. Is this the only vaccine for cervical cancer? There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV strains, HPV-16 and HPV-18. GSK says it plans to ...

GSK is to provide a supply of Cervarix® (Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed)) to four new GAVI demonstration projects at a significantly discounted ...

But rates of types 31/33/45, 47, and 45 were lower in vaccinated women, which the authors said suggests that the vaccines ...

[208] AS04 is another EU-registered adjuvant present in an HPV vaccine (Cervarix) as well as in a Hepatitis B vaccine (Fendrix® [GSK Biologicals]). For this adjuvant, no effect on any of the ...

Provincial health authorities said they want to create awareness around HPV and to limit its potential to spread cancer.

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

HPV vaccination and early detection are key to preventing cervical cancer in India. Experts emphasize awareness, affordable vaccines like CERVAVAC, and improved screening programs to reduce the ...